An observational study in Postoperative Complications, sponsored by Ángel Becerra-Bolaños, MD PhD. Completed at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-07.
Sponsored by Ángel Becerra-Bolaños, MD PhD · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 69 studies in Postoperative Complications with a site in Spain — 13 open to participants now, 15 under way, 1 of them phase 3. Postoperative Complications · Spain.
Among the 69 studies in Postoperative Complications with a site in Spain, this one is the 21st largest by enrollment of the 37 observational ones that give a count, is one of 7 that started in 2021, is one of 37 observational ones, and was the 42nd registered.
1,343 studies on the registry are indexed under Postoperative Complications; 314 are open to participants now.
Browse Postoperative Complications studies →13 of the 69 studies in Postoperative Complications with a site in Spain are open now. Recruiting first, the newest first:
University of Seville · Sites in Spain
Ages 18–80
Zealand Pharma · Sites in Spain, United States, Austria and 11 more countries
Ages 18–90
Carlos Alfredo Fraile Olivero, MD, PhD. · Sites in Spain
Ages 18+
Francisco Andres de la Gala · Sites in Spain
Ages 18+
Hospital Universitario de Gran Canaria Doctor Negrín · Sites in Spain
Ages 18+
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 200 Postoperative Complications studies recruiting now, 126 (63%) set no upper age limit and 31 (16%) stop at 75 or younger; 24 take children under 18; 25 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
69 studies; the count open now beside each. This study's row is marked.
First in 1998; this study’s year is marked. 7 started in 2021.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 350 is above the median of 251 across 541 observational studies indexed under Postoperative Complications.
Median enrollment 178 across the 32 interventional studies, 400 across the 37 observational. Of the 41 that completed or were terminated, 3 (7%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 69 have an industry lead sponsor. The 10 most frequent:
Ángel Becerra-Bolaños, MD PhD is the lead sponsor of 2 studies on the registry; none are open to participants now.
Ángel Becerra-Bolaños, MD PhD has 2 studies filed under Postoperative Complications — fewer than ten, so there is no comparison to draw.
5 of the studies in Postoperative Complications with a site in Spain that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04973397Centre hospitalier de l'Université de Montréal (CHUM)Vascular Events In Patients Undergoing Same-day Noncardiac Surgery (VALIANCE) Study | 2026-12 |
| NCT04794582Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y CajalPrevention of Incisional Hernia After Renal Transplantation | 2026-12 |
| NCT07461779Francisco Andres de la GalaEffect of Oxygen Administration in the Non-dependent Lung on Postoperative Complications After Lung Surgery | 2026-12-30 |
| NCT06732193Carlos Alfredo Fraile Olivero, MD, PhD.Fissios© and Postoperative Complications (FPoC Trial) | 2026-12-31 |
| NCT07771049Hospital Universitario La FeOpioid-Free Anesthesia in Colorectal Surgery, 2025 (OFA-CRC-2025) | 2027-07-20 |
Add all 5 to your calendar (.ics) → With an account.
Among the 69 studies in Postoperative Complications with a site in Spain, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Abdominal surgery represents the most frequent activity in the surgical block. Advances in surgical techniques and improvements in postoperative care imply the need for greater control of the surgical outcomes obtained and the comparison of results between services with the same characteristics with the help of assessment scales.
A prospective observational study will be carried out during 2021. All patients undergoing abdominal surgery will be included. Demographic variables, personal and surgical history, preoperative and intraoperative data, and variables related to surgery will be collected. At 30 days postoperatively, the clinical history of the patients will be reviewed and postoperative complications will be collected as well as the mortality that occurred. With these data, the POSSUM, the P-POSSUM, the Clinical Frailty Scale and the Charlson comorbidity index will be calculated.
Abdominal surgery represents the most frequent activity in the surgical block. Advances in surgical techniques and improvements in postoperative care imply the need for greater control of the surgical outcomes obtained and the comparison of results between services with the same characteristics with the help of assessment scales.
A prospective observational study will be carried out during 2021. All patients undergoing abdominal surgery will be included. Demographic variables, personal and surgical history, preoperative and intraoperative data, and variables related to surgery will be collected. At 30 days postoperatively, the clinical history of the patients will be reviewed and postoperative complications will be collected as well as the mortality that occurred. With these data, the POSSUM, the P-POSSUM and the Charlson comorbidity index will be calculated.
Once this data are collected, the following objectives will be met:
A prospective observational study will be carried out in which all patients undergoing gastrointestinal surgery will be included, both scheduled and urgently.
At 30 days postoperatively, the clinical records of the patients will be reviewed in order to establish the incidence of morbidity and mortality.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
POSSUM, the P-POSSUM, the Clinical frailty scale, and the Charlson comorbidity index will be calculated and compared to the outcomes obtained in our center.
Diagnostic Test: POSSUM
These scales will be calculated and compared to the outcomes obtained in our center.
Also known as: P-POSSUM, Charlson comorbidity index, Clinical frailty scale
Validate the POSSUM and P-POSSUM systems in patients undergoing gastrointestinal surgery
To compare the estimated morbidity and mortality with that observed.
Time frame: 30 days after surgery.
Analyze the correlation of estimated morbidity and mortality of the POSSUM and P-POSSUM with respect to that observed in scheduled surgery vs. emergencies.
To compare the estimated morbidity and mortality with that observed.
Time frame: 30 days after surgery.
Analyze the correlation of estimated morbidity and mortality of POSSUM and P-POSSUM with respect to that observed in laparoscopic surgery vs. laparotomy
To compare the estimated morbidity and mortality with that observed
Time frame: 30 days after surgery.
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: Undecided
Ran from Mar 2021 to primary completion in Mar 2025, 48 months.
Of 276 non-industry observational studies under Postoperative Complications, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 39. This study's 48 months is above that.
Counting every sponsor, half of 281 studies reached it within 22 months; a quarter within 10 and three quarters within 39.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Ángel Becerra-Bolaños, MD PhD